ALTO
Alto Ingredients, Inc.
Next earnings Aug 4, 2026 · consensus $0.09 EPS, $236M rev
Last earnings -7.2% on 2026-05-06
$5.19
▲ +4.22%$5.19▲ +367.57%
over 1Y
L $0.92EODHDH $5.99
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.2%
1W-0.6%
1M-2.1%
3M+15.1%
YTD+95.1%
1Y+367.6%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy
Conservative balance sheet (liabilities/equity 0.59x); but revenue declined -4.9% YoY.
Revenue (FY2025) $918M · FY2025
The read
Weak on both the fundamentals and the price — little to like at the current level.
Alto Ingredients, Inc. shows $918M in FY2025 revenue (-4.9% YoY), a 1.5% net margin, and 5.4% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.21B | $1.34B | $1.22B | $965M | $918M |
| Gross profit | $67.8M | -$27.6M | $15.7M | $9.72M | $34.9M |
| Operating income | $40.1M | -$61.4M | -$23.8M | -$51.7M | $7.36M |
| Net income | $46.1M | -$41.6M | -$28.0M | -$59.0M | $13.3M |
| Diluted EPS | $0.61 | -$0.60 | -$0.40 | -$0.82 | $0.16 |
| Net margin | 3.8% | -3.1% | -2.3% | -6.1% | 1.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$457M
EV / EBITDA14.0
EV / Sales0.5
EV / FCF52.9
P / FCF46.4
PEG (trailing)0.26
Earnings yield3.3%
FCF yield2.2%
Quality & risk
ROIC (est.)1.8%
Free cash flow$8.65M
Total debt$79.6M
Net cash-$56.2M
Altman Z-Score1.47 distress
Piotroski F-Score5/9
Capital returns
Buyback yield0.9%
Dividend yield (est.)—
Shareholder yield0.9%
Shares Δ YoY+0.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
- 8-K Officer / director change2026-06-23
- S-3 Shelf registration (potential raise)2026-05-08
- 10-Q Quarterly report2026-05-08
- 8-K Earnings results2026-05-06
- DEF 14A Proxy statement2026-04-30
- 10-K Annual report2026-03-13
- 8-K Earnings results2026-03-04
- 8-K Officer / director change2025-11-26
- 10-Q Quarterly report2025-11-07
Recent filings
all on EDGAR ↗4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗S-8Filing2026-06-23open ↗8-KPeriod ending 2026-06-232026-06-23open ↗EFFECTFiling2026-05-22open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-122026-05-14open ↗S-3Filing2026-05-08open ↗10-QPeriod ending 2026-03-312026-05-08open ↗8-KPeriod ending 2026-05-062026-05-06open ↗
Frequently asked
- Is Alto Ingredients, Inc. (ALTO) a buy?
- ALTO currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.59x); but revenue declined -4.9% YoY.
- What is ALTO's fair value?
- A Modified-Graham model based on ALTO's SEC fundamentals estimates a fair value of about $5.68. It is an estimate from reported earnings, not a price target.
- Is ALTO overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, ALTO currently appears fairly valued relative to its SEC-grounded earnings power.
- What is Alto Ingredients, Inc.'s quality score?
- ALTO scores 65.90196078431372/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000778164, latest 10-Q filed 2026-05-08) · EODHD · as of 6/26/2026, 6:10:53 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.